Cargando…

18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art

BACKGROUND: Metabolic information provided by 18F-FDG PET/CT are useful for initial staging, therapy planning, response evaluation, and to a lesser extent for the follow-up of non-small cell lung cancer (NSCLC). To date, there are no established clinical guidelines in treatment response and early de...

Descripción completa

Detalles Bibliográficos
Autores principales: Castello, Angelo, Rossi, Sabrina, Lopci, Egesta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493792/
https://www.ncbi.nlm.nih.gov/pubmed/31886757
http://dx.doi.org/10.2174/1874471013666191230144821